Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  necitumumab
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients with EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PhI-77, NCI-2015-01053, 9898, NCT02496663
Start Over